Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLENVU versus sodium picosulfate for bowel cleansing before pediatric colonoscopy
NL-OMON60367Phase 3Recruiting
- Sponsor
- Norgine
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of polyethylene glycol + electrolytes + ascorbic acid and sodium picosulfate in colonic diseases (2 arms), sponsored by Norgine. Primary endpoint: Success rate of bowel cleansing based on BBPS. Started Apr 2026; status: recruiting.
02
Drugs
polyethylene glycol + electrolytes + ascorbic acidsodium picosulfate
03
Conditions
colonic diseases
Beyond the preview
Go deeper on NL-OMON60367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60367.